Clinical Trial: The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With C
Brief Summary: This is an 18-week, prospective, multi-center, randomized, double-blind, placebo-controlled, (1:1) parallel-group study.
Detailed Summary:
Sponsor: Eisai Limited
Current Primary Outcome: Cognitive function.
Original Primary Outcome: cognitive function
Current Secondary Outcome:
Original Secondary Outcome:
- other cognitive assessments
- functional assessments
- safety
- tolerability
Information By: Eisai Inc.
Dates:
Date Received: February 17, 2005
Date Started: February 2005
Date Completion:
Last Updated: November 2, 2015
Last Verified: November 2015